Home > Insider Trading > Alpine Air Express Inc > Profile

Alpine Air Express Inc (ALPN)

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

Sector: Air Transportation, Nonscheduled

Related Insiders

L. Ronald Pattison, Director, 2011-04-19
Eugene Mallette, Large Shareholder, Officer, Director, 2009-04-01

Hedge Fund Popularity

Display

Display Large Version

Insider Trading: Purchases See All

Insider	Price	Amount	Relationship	Remaining Holdings	Date	Form 4
Pattison	$0.10	356,298	Director	427,098	2011-03-14	Filing

News See All

Hedge Fund and Insider Trading News: GoldenTree Asset Management, Third Point LLC, HITE, Mountain Province Diamonds, Inc. (MPVDF), ComSovereign Holding Corp (COMS), and More

Pierre de Chillaz, a former partner at GoldenTree Asset Management, is preparing to start his own hedge fund, joining a growing list of startups as investors return to the industry.

Keep Reading →

September 24th, 2021 - Hedge Funds Insider Trading

Were Hedge Funds Right About Alpine Immune Sciences, Inc. (ALPN)?

In this article we are going to use hedge fund sentiment as a tool and determine whether Alpine Immune Sciences, Inc. (NASDAQ:ALPN) is a good investment right now.

Keep Reading →

July 30th, 2021 - Hedge Funds News

Is ALPN A Good Stock To Buy Now?

We at Insider Monkey have gone over 817 13F filings that hedge funds and prominent investors are required to file by the SEC The 13F filings show the funds' and investors' portfolio positions as of September...

Keep Reading →

December 11th, 2020 - Hedge Funds News

Hedge Funds Never Been Less Bullish On Alpine Immune Sciences, Inc. (ALPN)

At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (Recession is Imminent: We Need A Travel Ban NOW).

Keep Reading →

June 10th, 2020 - Hedge Funds News

Is Alpine Immune Sciences, Inc. (ALPN) A Good Stock To Buy?

Hedge funds and large money managers usually invest with a focus on the long-term horizon and, therefore, short-lived dips or bumps on the charts, usually don't make them change their opinion towards ...

Keep Reading →

December 22nd, 2019 - Hedge Funds News

13D Filing: OrbiMed Advisors and Alpine Immune Sciences Inc. (ALPN)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of § 240.13d‑1(e), 240....

Keep Reading →

January 26th, 2018 - Hedge Funds

13D Filing: James E. Flynn and Alpine Immune Sciences Inc. (ALPN)

You can access the original SEC filing by clicking here.

Keep Reading →

August 23rd, 2017 - Hedge Funds

13D Filing: OrbiMed Advisors and Alpine Immune Sciences Inc. (ALPN)

Keep Reading →

August 3rd, 2017 - Hedge Funds

13D Filing: James E. Flynn and Alpine Immune Sciences Inc. (ALPN)

933,100 (comprised of shares held by Deerfield Special Situations Fund, Deerfield Private Design, Deerfield Private Design International, Deerfield Private Design II and Deerfield Private Design International...

Keep Reading →

July 28th, 2017 - Hedge Funds